Immuno-potentiating pathway of HBsAg-HBIG immunogenic complex visualized

Human Vaccines and Immunotherapeutics

Volumn 12, Issue 1, 2016, Pages 77-84

  Liu, Hu ^a,b   Geng, Shuang ^a   Wang, Bo ^a   Wu, Bing ^b   Xie, Xiaoping ^b   Wang, Shuang ^b   Zhong, Yiwei ^a   Wang, Xuanyi ^a   Qu, Di ^a   Wen, Yumei ^a   Wang, Bin ^a  

^a FUDAN UNIVERSITY   (China)

^b CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

Chronic hepatitis B; Cross presentation; Dendritic cells; HBsAg anti HBs complex; Therapeutic vaccine

Indexed keywords

GAMMA INTERFERON; GRANZYME B; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PERFORIN; TUMOR NECROSIS FACTOR ALPHA; ANTIGEN ANTIBODY COMPLEX; HEPATITIS B HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTATION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CROSS PRESENTATION; FEMALE; FLOW CYTOMETRY; HEPATITIS B; IMAGE ANALYSIS; IMAGE PROCESSING; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOPOTENTIATION; MOUSE; NONHUMAN; SIMULATION; T LYMPHOCYTE; VIRUS LOAD; ANIMAL; ANTIGEN PRESENTING CELL; C57BL MOUSE; ENDOCYTOSIS; IMMUNOLOGY; METABOLISM; PROTEIN TRANSPORT;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; ANTIGEN-PRESENTING CELLS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; ENDOCYTOSIS; FEMALE; HEPATITIS B SURFACE ANTIGENS; IMMUNOGLOBULINS; MICE, INBRED C57BL; PROTEIN TRANSPORT;

EID: 84961771230     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.1080/21645515.2015.1072660     Document Type: Article

References (24)

1. Weekly epidemiological record. World health organization genebra. Suica, CH; 2009.
2. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005; 5:215-29; PMID:15738952; http://dx.doi.org/10.1038/nri1573
3. Chisari FV, Ferrari C. Hepatitis B Virus Immunopathogenesis. Ann Rev Immunol 1995; 13:29-60; PMID:7612225; http://dx.doi.org/10.1146/annurev.iy.13.040195.000333
4. Mancini-Bourgine M, Fontaine H, Bréchot C, Pol S, Michel M-L. Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers. Vaccine 2006; 24:4482-9; PMID:16310901; http://dx.doi.org/10.1016/j.vaccine.2005.08.013
5. Buchmann P, Dembek C, Kuklick L, Jäger C, Tedjokusumo R, von Freyend MJ, Drebber U, Janowicz Z, Melber K, Protzer U. A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice. Vaccine 2013; 31:1197-203; PMID:23306359; http://dx.doi.org/10.1016/j.vaccine.2012.12.074
6. Zheng B, Ng M, He L, Yao X, Chan K, Yuen K, Wen Y. Therapeutic efficacy of hepatitis B surface antigenantibodies- recombinant DNA composite in HBsAg transgenic mice. Vaccine 2001; 19:4219-27; PMID:11457548
7. Yao X, Zheng B, Zhou J, Xu D-Z, Zhao K, Sun S-H, Yuan Z-H, Wen Y-M. Therapeutic effect of hepatitis B surface antigen-antibody complex is associated with cytolytic and non-cytolytic immune responses in hepatitis B patients. Vaccine 2007; 25:1771-9; PMID:17224217; http://dx.doi.org/10.1016/S0264-410X(01)00158-X
8. Xu D-Z, Zhao K, Guo L-M, Li L-J, Xie Q, Ren H, Zhang J-M, Xu M, Wang H-F, Huang W-X, et al. A randomized controlled phase IIb trial of antigen-antibody immunogenic complex therapeutic vaccine in chronic hepatitis B patients. PloS one 2008; 3:e2565; PMID:18596958; http://dx.doi.org/10.1371/annotation/8b913538-74f4-4560-b700-0936a8e35847
9. Wen Y, Wu X, Hu D, Zhang Q, Guo S. Hepatitis B vaccine and anti-HBs complex as approach for vaccine therapy. Lancet 1995; 345:1575-6; PMID:7791465; http://dx.doi.org/10.1016/S0140-6736(95)91126-X
10. Schuurhuis D, van Montfoort N, Ioan-Facsinay A, Jiawan R, Camps M, Nouta J, Melief C, Verbeek J, Ossendorp F. Immune complex-loaded dendritic cells are superior to soluble immune complexes as antitumor vaccine. J Immunol 2006; 176:4573-80; PMID:16585547; http://dx.doi.org/10.4049/jimmunol.176.8.4573
11. Schuurhuis D, Ioan-Facsinay A, Nagelkerken B, van Schip J, Sedlik C, Melief C, Verbeek J, Ossendorp F. Antigen-antibody immune complexes empower dendritic cells to efficiently prime specific CD8C CTL responses in vivo. J Immunol 2002; 168:2240-6; PMID:11859111; http://dx.doi.org/10.4049/jimmunol.168.5.2240
12. Regnault A, Lankar D, Lacabanne V, Rodriguez A, Théry C, Rescigno M, Saito T, Verbeek S, Bonnerot C, Ricciardi-Castagnoli P, et al. Fcgamma receptormediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J Exp Med 1999; 189:371-80; PMID:9892619; http://dx.doi.org/10.1084/jem.189.2.371
13. van Montfoort N, Camps M, Khan S, Filippov D, Weterings J, Griffith J, Geuze H, van Hall T, Verbeek J, Melief C, et al. Antigen storage compartments in mature dendritic cells facilitate prolonged cytotoxic T lymphocyte cross-priming capacity. Proc Natl Acad Sci U S A 2009; 106:6730-5; PMID:19346487; http://dx.doi.org/10.1073/pnas.0900969106
14. León B, Ballesteros-Tato A, Randall TD, Lund FE. Prolonged antigen presentation by immune complex– binding dendritic cells programs the proliferative capacity of memory CD8 T cells. J Exp Med 2014; 211:1637-55; PMID:25002751; http://dx.doi.org/10.1084/jem.20131692
15. Huotari J, Helenius A. Endosome maturation. EMBO J 2011; 30:3481-500; PMID:21878991; http://dx.doi.org/10.1038/emboj.2011.286
16. Bevan M. Cross-priming. Nat Immunol 2006; 7:363-5; PMID:16550200; http://dx.doi.org/10.1038/ni0406-363
17. Wagner C, Grotzke J, Cresswell P. Intracellular events regulating cross-presentation. Front Immunol 2012; 3:138; PMID:22675326; http://dx.doi.org/10.3389/fimmu.2012.00138
18. Kurts C. Molecular and cell-biological mechanisms of antigen cross-presentation. Front Immunol 2013; 4:51; PMID:23450983; http://dx.doi.org/10.3389/fimmu.2013.00051
19. Desjardins M. ER-mediated phagocytosis: a new membrane for new functions. Nat Rev Immunol 2003; 3:280-91; PMID:12669019; http://dx.doi.org/10.1038/nri1053
20. Watts C. Phagocytosis: How the Phagosome Became the Phag-ER-some. Curr Biol 2002; 12:R666-R8; PMID:12361588; http://dx.doi.org/10.1016/S0960-9822(02)01163-6
21. Shen Z, Reznikoff G, Dranoff G, Rock KL. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. The J Immunol 1997; 158:2723-30; PMID:9058806
22. Zou L, Zhou J, Zhang J, Li J, Liu N, Chai L, Li N, Liu T, Li L, Xie Z, et al. The GTPase Rab3b/3c-positive recycling vesicles are involved in cross-presentation in dendritic cells. Proc Nat Acad Sci U S A 2009; 106:15801-6; PMID:19717423; http://dx.doi.org/10.1073/pnas.0905684106
23. Imai J, Hasegawa H, Maruya M, Koyasu S, Yahara I. Exogenous antigens are processed through the endoplasmic reticulum-associated degradation (ERAD) in cross-presentation by dendritic cells. Int Immunol 2005; 17:45-53; PMID:15546887; http://dx.doi.org/10.1093/intimm/dxh184
24. Shakushiro K, Yamasaki Y, Nishikawa M, Takakura Y. Efficient scavenger receptor-mediated uptake and crosspresentation of negatively charged soluble antigens by dendritic cells. Immunology 2004; 112:211-8; PMID:15147564; http://dx.doi.org/10.1111/j.1365-2567.2004.01871.x